Sorry, there was a problem.

An unexpected error occurred and your request couldn't be handled. Please call a Dignity Health representative at
(844) 274-8497
Chat with us here.

Reference code:

Cardiology & Electrophysiology Symposium

Concepts & Controversies         

Thank you for your interest in Dignity Health Heart and Vascular Institute of Greater Sacramento's 28th Annual Cardiology & Electrophysiology CME Symposium 2018. 

Event Details 

Saturday, October 20, 2018
7:00 a.m. to 4:30 p.m.
Hyatt Regency Sacramento
1209 L Street
Sacramento, CA 95814 


7:00 a.m. Registration, breakfast, and networking     

7:30 a.m. Welcome    

4:30 p.m. Closing Remarks/Adjourn


Our featured presentations will include:

New Hypertension Guidelines

Prakash Deedwania, MD, FACC, FACP, FAHA, FHFSA, FESC

Lipid Lowering in 2018: How Low Should We Go?

Prakash Deedwania, MD, FACC, FACP, FAHA, FHFSA, FESC

Aortic Disease: Interventional and Surgical Innovations

Kapil Sharma, MD, FRCSC

Chronic Heart Failure: The Future is Now

Munir Janmohamed, MD, FACC

Artificial Intelligence in Cardiology: Hope or Hype?

Mintu Turakhia, MD, MAS, FHRS, FACC, FAHA

Revamping Process and Efficiency for Atrial Fibrillation Ablation

Mintu Turakhia, MD, MAS, FHRS, FACC, FAHA

Percutaneous Aortic and Mitral Therapies

Michael Chang, MD, FACC

Patent Foramen Ovale, Cryptogenic Stroke, and Migraine   

Jonathan M. Tobis, MD, MSCAI, FACC

Premature Ventricular Contractions and Ventricular Tachycardia 
Ablation in Structurally Normal and Abnormal Hearts 

Arash Aryana, MS, MD, FACC, FHRS

Angioplasty for Stable and Unstable Ischemic Syndromes: The Orbita Trial in Perspective

Jonathan M. Tobis, MD, MSCAI, FACC

Management of Patients with Critical Limb Ischemia

Suhail Dohad, MD, FACC

Role of Inflammation in Cardiovascular Disease: Myth or a Treatable Reality?

Sanjay Kaul, MD, FACC, FAHA

Current Approach to Management of Coronary Chronic Total Occlusion

Suhail Dohad, MD, FACC

Advanced Heart Failure: The Future is Now

Munir Janmohamed, MD, FACC


At the conclusion of our program, participants should be able to implement the following changes to their professional practice:

  • Integrate new guidelines to better manage patients with hypertension.
  • Institute current lipid lowering guidelines and implement aggressive therapies for improved patient outcomes.
  • Identify patients at risk with aortic catastrophe, and facilitate the pre-surgical, post-surgical care and management of aortic dissections. 
  • Apply current advancements in ACC/AHA guideline directed therapy for heart failure reduced ejection fraction patients to improve outcomes.  
  • Determine where new technology advances could ultimately be incorporated into cardiology workflow or clinical care.
  • Identify patients for percutaneous aortic and mitral therapies and discuss efficacy of these therapies with patients. 
  • Facilitate rapid recovery after atrial fibrillation ablation, which may be extended to other cardiovascular procedures.
  • Recognize the symptoms of a cryptogenic stroke and order the appropriate tests to look for a Patent Foramen Ovale.
  • Recognize the presentation, prognosis, and indications of catheter ablation of ventricular arrhythmias encountered in structurally normal versus abnormal hearts and understand where catheter ablation fits in.
  • Assess symptomatic patients with coronary artery disease for diagnostic angiograms and interventions if there is functionally significant disease.  
  • Recognize, and diagnose patients with critical limb ischemia for early management to avoid amputation.
  • Discuss with patients the biological basis and evidence for the role of inflammation in cardiovascular disease.
  • Evaluate patients with chronic total occlusion and ischemic heart disease for management and treatment. 
  • Identify patients with advanced heart failure earlier and discuss treatment options with them.


  • Dr. Baron receives research support and/or honoraria as a speaker for Novartis, Alacea, Regeneron/Sanofi, Amgen, Esai, and Pfizer/BMS.
  • Dr. O’Neill receives honoraria as a speaker for Bristol Myers Squibb, and Pfizer, and research support as an investigator for Milestone Pharmaceuticals, Boston Scientific, Medtronic, Johnson & Johnson, and St. Jude Medical.
  • Dr. Chang receives honorarium as a speaker for Medtronic. 
  • Dr. Kaul receives fees as a consultant for Boehringer Ingelheim, Novo Nordisk, and Johnson & Johnson.
  • Dr. Aryana receives research support and/or speaker and consulting honoraria from Abiomed, Abbott, Biosense Webster, Boston Scientific, Janssen Pharmaceuticals, and Medtronic.
  • Dr. Deedwania receives fees as a Consultant and Advisor for Amgen, Sanofi, and Janssen, and received a research grant from Novartis.
  • Dr. Turakhia receives fees as a speaker for Medscape/, receives grant support and fees as a consultant for Medtronic, Boehringer Ingelheim, Cardiva Medical, receives fees as a consultant for Akebia, iRhythm, St. Jude Medical, Precision Health Economics, receives grant support from Janssen Inc., AstraZeneca, Veterans Health Administration, receives fees as a consultant and is a stock holder for AliveCor, Zipline Medical, and iBeat Inc. 
  • Dr. Janmohamed receives fees as a speaker for Novartis and Actelion.

The potential conflicts of interest have been resolved and determined the presentations are without bias.

  • Dr. Sharma, Dr. Tobis, Dr. Dohad, Dignity Health Sacramento CME committee members, and all other planners’ involved and able to influence the content of this presentation have reported no relevant financial relationships/interest with any commercial entities that may have ties to this presentation.

This educational activity is supported in part by educational grants from Abbott/St. Jude, Boston Scientific, Medtronic, and Novartis.

Accreditation Statement:

Dignity Health Sacramento is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.

Credit Designation:

Dignity Health Sacramento designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.